+Search query
-Structure paper
Title | Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach. |
---|---|
Journal, issue, pages | Br. J. Pharmacol., Vol. 174, Page 2209-2224, Year 2017 |
Publish date | May 16, 2016 (structure data deposition date) |
Authors | Ryan, A. / Polycarpou, E. / Lack, N.A. / Evangelopoulos, D. / Sieg, C. / Halman, A. / Bhakta, S. / Eleftheriadou, O. / McHugh, T.D. / Keany, S. ...Ryan, A. / Polycarpou, E. / Lack, N.A. / Evangelopoulos, D. / Sieg, C. / Halman, A. / Bhakta, S. / Eleftheriadou, O. / McHugh, T.D. / Keany, S. / Lowe, E.D. / Ballet, R. / Abuhammad, A. / Jacobs, W.R. / Ciulli, A. / Sim, E. |
External links | Br. J. Pharmacol. / PubMed:28380256 |
Methods | X-ray diffraction |
Resolution | 2.102 - 2.68 Å |
Structure data | PDB-5jz9: PDB-5jzb: PDB-5jzs: |
Chemicals | ChemComp-6OR: ChemComp-HOH: ChemComp-6OT: ChemComp-PO4: ChemComp-FGZ: |
Source |
|
Keywords | HYDROLASE / HsaD / M. tuberculosis / Cholesterol / Inhibitor / MCP-hydrolase / infection |